Finding the best timing for stem cell transplants in leukemia patients
Optimizing treatment decision by accounting for longitudinal biomarker trajectories and competing risks of each individual
This study is looking at how to better time stem cell transplants for people with chronic myeloid leukemia (CML) by analyzing their health data over time, so that patients can get personalized treatment advice that weighs the benefits and risks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11077755 on NIH RePORTER |
What this research studies
This research aims to develop advanced statistical methods to evaluate treatment strategies for patients with chronic myeloid leukemia (CML) by analyzing their biomarker data over time. The focus is on determining the optimal timing for stem cell transplants, which can cure leukemia but come with significant risks. By using comprehensive models, the research seeks to provide personalized treatment recommendations based on individual disease progression, helping to balance the benefits and risks of different treatment options. This approach is particularly important as randomized controlled trials are not feasible for this type of decision-making.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic myeloid leukemia who are considering treatment options, particularly stem cell transplants.
Not a fit: Patients with other types of leukemia or those who are not candidates for stem cell transplants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment plans for leukemia patients, potentially improving survival rates and quality of life.
How similar studies have performed: While the specific statistical methods being developed are novel, similar approaches in personalized medicine have shown promise in optimizing treatment strategies for various conditions.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Huang, Xuelin — University of Tx Md Anderson Can Ctr
- Study coordinator: Huang, Xuelin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.